OptimizeRx Corp (OPRX) has a current Price-to-Book (P/B) ratio of 1.89. Compared to its 3-year average P/B ratio of 1.69, the current P/B ratio is approximately 11.85% higher. Relative to its 5-year average P/B ratio of 3.51, the current P/B ratio is about -46.15% higher. OptimizeRx Corp (OPRX) has a Forward Free Cash Flow (FCF) yield of approximately 5.08%. Compared to its 3-year average FCF yield of 0.84%, the current FCF yield is approximately 504.59% lower. Relative to its 5-year average FCF yield of 0.78%, the current FCF yield is about 554.11% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for OPRX competitors is 0.96, providing a benchmark for relative valuation. OptimizeRx Corp Corp (OPRX.O) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of 22.33%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of OPRX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of OPRX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is OPRX currently overvalued or undervalued?

What is OptimizeRx Corp (OPRX) fair value?

OPRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of OptimizeRx Corp (OPRX) is between to according to relative valuation method.

How does OPRX's valuation metrics compare to the industry average?

The average P/S ratio for OPRX's competitors is 0.96, providing a benchmark for relative valuation. OptimizeRx Corp Corp (OPRX) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of 22.33%, this premium appears sustainable.

What is the current P/B ratio for OptimizeRx Corp (OPRX) as of Mar 03 2026?

As of Mar 03 2026, OptimizeRx Corp (OPRX) has a P/B ratio of 1.89. This indicates that the market values OPRX at 1.89 times its book value.

What is the current FCF Yield for OptimizeRx Corp (OPRX) as of Mar 03 2026?

As of Mar 03 2026, OptimizeRx Corp (OPRX) has a FCF Yield of 5.08%. This means that for every dollar of OptimizeRx Corp's market capitalization, the company generates 5.08 cents in free cash flow.

What is the current Forward P/E ratio for OptimizeRx Corp (OPRX) as of Mar 03 2026?

As of Mar 03 2026, OptimizeRx Corp (OPRX) has a Forward P/E ratio of 17.59. This means the market is willing to pay $17.59 for every dollar of OptimizeRx Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for OptimizeRx Corp (OPRX) as of Mar 03 2026?

As of Mar 03 2026, OptimizeRx Corp (OPRX) has a Forward P/S ratio of 2.03. This means the market is valuing OPRX at $2.03 for every dollar of expected revenue over the next 12 months.

OPRX Valuation